Home Newsfeeds Summit Insights Group Upgrades Applied Materials to Buy

Summit Insights Group Upgrades Applied Materials to Buy

Summit Insights Group analyst Kinngai Chan upgrades Applied Materials (NASDAQ:AMAT) from Hold to Buy.

byBenzinga Newsdesk

November 18, 2022

1 minute read

Summit Insights Group analyst Kinngai Chan upgrades Applied Materials (NASDAQ:AMAT) from Hold to Buy.

Bitcoin ETFs Could Propel King Crypto Above Gold’s Market Cap, Says Analyst: ‘These Are Very Conservative Numbers’

By Benzinga Neuro

April 15, 10:38 PM

Renowned cryptocurrency analyst Willy Woo has projected that the introduction of Bitcoin ETFs could potentially drive Bitcoin’s (CRYPTO: BTC) price to surpass that of gold.

ARKB

Neurosurgery Focused Integra LifeSciences Bolsters Its ENT Portfolio With $275M Acquisition Deal

By Vandana Singh

December 13, 12:20 PM

Integra LifeSciences Holdings Corporation (NASDAQ: IART) agreed to acquire Acclarent Inc.

IART

Teva Appoints Dr. R. Ananthanarayanan As New CEO For Teva API, Its Active Pharmaceutical Ingredients Business

By Benzinga Newsdesk

November 7, 6:44 PM

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced the appointment of Dr. R. Ananthanarayanan (Ananth) as CEO of its Teva Active Pharmaceutical Ingredients business (Teva api). Dr. Ananth will lead

TEVA

News

‘Mexican Senator To File Psychedelics Legalization Bill, With U.S. Congressman Backing International Reform Push’ – Marijuana Moment

By Happy Mohamed

January 27, 1:49 PM

https://www.marijuanamoment.net/mexican-senator-to-file-psychedelics-legalization-bill-with-u-s-congressman-backing-international-reform-push/ A Mexican senator announced on Wednesday that she will be introducing a bill

CMPS

Summit Insights Group Upgrades Applied Materials to Buy

Related Posts

Bitcoin ETFs Could Propel King Crypto Above Gold’s Market Cap, Says Analyst: ‘These Are Very Conservative Numbers’

Neurosurgery Focused Integra LifeSciences Bolsters Its ENT Portfolio With $275M Acquisition Deal

Teva Appoints Dr. R. Ananthanarayanan As New CEO For Teva API, Its Active Pharmaceutical Ingredients Business

‘Mexican Senator To File Psychedelics Legalization Bill, With U.S. Congressman Backing International Reform Push’ – Marijuana Moment